Thursday, 26 October 2017

October Strategy: GSK

GSK reported good Q3 results but priced dropped so I bought some more. At this price GSK, I am in regular accumulation mode for GSK.

Currently hold about S$20k+ worth, would like to at least double the holding.

GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER Total EPS 24.8p, +49% AER, +46% CER; Adjusted EPS 32.5p, +3% AER, flat CER


In other portfolio news, topped up my Euro Stoxx 50 ETF, and WPP

No comments:

Post a Comment